XML 25 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 276 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2012
Operating activities:      
Net loss $ (9,455) $ (4,988) $ (250,335)
Adjustments to reconcile net loss to net cash used for operating activities:      
Depreciation and amortization 179 134 7,677
Loss on property held for resale     110
Amortization of discounts and premiums on investments     (1,704)
Stock compensation expense 815 616 14,700
Increase (decrease) in fair value of warrants 900 (1,254) (11,389)
Inventory write downs and reserves     2,240
Stock issued pursuant to license agreement     3,300
Provision for losses on accounts receivable     204
Changes in operating assets and liabilities:      
Receivables (2) 7 (260)
Inventories     (2,335)
Other current assets 183 (13) (433)
Accounts payable and accrued expenses 421 (592) 3,152
Accrued employee benefits 356 (329) 1,398
Net cash used for operating activities (6,603) (6,419) (233,675)
Investing activities:      
Organizational costs     (73)
Purchase of short-term investments     (217,041)
Maturities of short-term investments     218,745
Property and equipment purchases (82) (148) (7,299)
Proceeds from sale of property held for resale     400
Net cash used for investing activities (82) (148) (5,268)
Financing activities:      
Net proceeds from issuance of preferred stock 37,723   89,370
Net proceeds from issuance of common stock and warrants 176 4 184,884
Payments received for stock purchase rights and other, net     3,500
Proceeds from long-term debt     751
Principal payments under long-term debt obligations (11) (64) (2,811)
Other, net     (18)
Net cash provided by (used for) financing activities 37,888 (60) 275,676
Net increase (decrease) in cash and cash equivalents 31,203 (6,627) 36,733
Cash and cash equivalents at beginning of period 5,530 31,248  
Cash and cash equivalents at end of period 36,733 24,621 36,733
Supplemental cash flow information      
Accretion of convertible preferred stock $ 289   $ 1,257